School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Department of Congenital Heart Disease, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
J Magn Reson Imaging. 2021 May;53(5):1446-1457. doi: 10.1002/jmri.27426. Epub 2020 Nov 6.
Improvements in outcomes for patients with congenital heart disease (CHD) have increased the need for diagnostic and interventional procedures. Cumulative radiation risk is a growing concern. MRI-guided interventions are a promising ionizing radiation-free, alternative approach.
To assess the feasibility of MRI-guided catheterization in young patients with CHD using advanced visualization passive tracking techniques.
Prospective.
A total of 30 patients with CHD referred for MRI-guided catheterization and pulmonary vascular resistance analysis (median age/weight: 4 years / 15 kg).
FIELD STRENGTH/SEQUENCE: 1.5T; partially saturated (pSAT) real-time single-shot balanced steady-state free-precession (bSSFP) sequence.
Images were visualized by a single viewer on the scanner console (interactive mode) or using a commercially available advanced visualization platform (iSuite, Philips). Image quality for anatomy and catheter visualization was evaluated by three cardiologists with >5 years' experience in MRI-catheterization using a 1-5 scale (1, poor, 5, excellent). Catheter balloon signal-to-noise ratio (SNR), blood and myocardium SNR, catheter balloon/blood contrast-to-noise ratio (CNR), balloon/myocardium CNR, and blood/myocardium CNR were measured. Procedure findings, feasibility, and adverse events were recorded. A fraction of time in which the catheter was visible was compared between iSuite and the interactive mode.
T-test for numerical variables. Wilcoxon signed rank test for categorical variables.
Nine patients had right heart catheterization, 11 had both left and right heart catheterization, and 10 had single ventricle circulation. Nine patients underwent solely MRI-guided catheterization. The mean score for anatomical visualization and contrast between balloon tip and soft tissue was 3.9 ± 0.9 and 4.5 ± 0.7, respectively. iSuite provided a significant improvement in the time during which the balloon was visible in relation to interactive imaging mode (66 ± 17% vs. 46 ± 14%, P < 0.05).
MRI-guided catheterizations were carried out safely and is feasible in children and adults with CHD. The pSAT sequence offered robust and simultaneous high contrast visualization of the catheter and cardiac anatomy.
2 TECHNICAL EFFICACY STAGE: 1.
先天性心脏病(CHD)患者的治疗效果得到改善,这使得他们对诊断和介入治疗的需求增加。累积辐射风险日益受到关注。MRI 引导的介入治疗是一种很有前途的非电离辐射替代方法。
使用先进的可视化被动跟踪技术评估 MRI 引导下心导管术在小儿 CHD 中的可行性。
前瞻性。
共 30 例 CHD 患者,因 MRI 引导下心导管术和肺血管阻力分析而就诊(中位年龄/体重:4 岁/15kg)。
磁场强度/序列:1.5T;部分饱和(pSAT)实时单次平衡稳态自由进动(bSSFP)序列。
由一名具有 5 年以上 MRI 心导管检查经验的观察者在扫描仪控制台(交互模式)或使用商业上可用的先进可视化平台(iSuite,Philips)上对图像进行可视化。三名具有 5 年以上 MRI 心导管检查经验的心脏病专家使用 1-5 分制(1,差,5,优)评估解剖结构和导管可视化的图像质量。测量导管球囊的信噪比(SNR)、血液和心肌的 SNR、导管球囊/血液对比噪声比(CNR)、球囊/心肌 CNR 和血液/心肌 CNR。记录导管发现、可行性和不良事件。比较 iSuite 和交互模式下导管可见时间的分数。
数值变量的 t 检验。分类变量的 Wilcoxon 符号秩检验。
9 例患者行右心导管术,11 例患者行左、右心导管术,10 例患者行单心室循环。9 例患者仅行 MRI 引导下心导管术。球囊尖端与软组织之间的解剖结构和对比度的平均评分为 3.9±0.9 和 4.5±0.7。iSuite 显著改善了与交互成像模式相比球囊可见的时间(66±17%比 46±14%,P<0.05)。
MRI 引导下心导管术在小儿和成人 CHD 患者中是安全可行的。pSAT 序列可同时提供导管和心脏解剖结构的高对比度可视化。
2 技术功效分级:1。